Krystal Biotech Inc (KRYS)
Debt-to-capital ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 778,641 | 522,231 | 593,576 | 292,084 | 202,914 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2023 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $778,641K)
= 0.00
The debt-to-capital ratio for Krystal Biotech Inc has consistently been 0.00 from 2019 to 2023. This indicates that the company has not utilized debt as a source of capital in its capital structure. A debt-to-capital ratio of 0.00 suggests that the company is primarily financed through equity, which can be viewed positively by investors and creditors as it signifies lower financial risk and potential stability. Krystal Biotech's consistent zero debt-to-capital ratio over the years reflects a strong financial position and a conservative approach to managing its capital structure.
Peer comparison
Dec 31, 2023